Completion of the Share Capital Decrease of the Al Barsha’a Pharmaceutical Industries Co. (Alkindi Pharmaceutical Industries Company)
التاريخ
Ref. :8/11/2635
Date: 10/05/2017
Memo No.
(43/2017)
Members of SDC of Brokers and Custodians
Dear General Manager,
Subject: Completion of the Share Capital Decrease of the Al Barsha’a Pharmaceutical Industries Co. (Alkindi Pharmaceutical Industries Company)
| Greetings, | |
| Kindly be informed that the SDC has completed the process of decreasing the share capital of the Al Barsha’a Pharmaceutical Industries Company on Wednesday 10/05/2017. The share capital decrease was conducted based upon the company's General Assembly's resolution made in its extraordinary meeting held on 29/12/2016 which was granted the approval of the Ministry of Industry, Trade, and Supply on 17/04/2017 through: | |
| 1. | Decreasing the share capital of (617,966) shares by a cancellation of shares of the affected shareholders based upon the company's General Assembly's resolution made in its extraordinary meeting held on 05/08/2013. |
| 2. | Decreasing the share capital of (8,543,438) share/ JOD to redeem the company’s accumulated losses as of 31/12/2015. |
| Thereby, the SDC record for the Capital of the Al Barsha’a Pharmaceutical Industries Company indicates the following: | |
| # | Company Name | No. of shares decreased | Registered Share Capital |
ISIN
|
Company No. |
| 1. | Al Barsha’a Pharmaceutical Industries Co. | 9,161,404 | 572,509 | JO4120211019 | 141202 |
Kind Regards,
Khalil Naser
Chief Executive Officer
